AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

PicoRNAVirus and Uses Thereof

Summary

Lead Inventors: Ian LipkinProblem or Unmet Need:Respiratory tract infections may result in a wide spectrum of disease that ranges from minor discomfort to exacerbations of asthma and COPD/emphysema to acute fatal respiratory failure. During an investigation of Influenza-like illness (ILI) using methods that enable molecular detection and discovery of both cultivatable and non-cultivatable microbes, we discovered a novel picornavirus that was subsequently classified by the International Committee for Taxonomy of Viruses as the prototype of a new clade of picornaviruses (rhinovirus C) and determined to be globally distributed in association with significant pulmonary disease.This technology is directed to address a group of picornaviruses (rhinovirus C) associated with respiratory infection. This invention encompasses: Isolated nucleic acid sequences Peptides associated with isolated nucleic acid sequences Interfering RNA (iRNA) directed against relevant sequences Antibodies against relevant peptidesThis technology can be used to detect the presence or absence of the virus in a subject. The iRNA described in this invention could be used as therapeutic agents to lower viral titers in patients. This invention also describes methods for inducing an immune response against the virus in a subject.

Technology Benefits

Detects the novel virus Offers rapid and specific detection of the virus Treatment in the form of a specific iRNA can be tailored to the diagnosis Offers a method of vaccination such that a specific immune response against the virus can be inducedOpportunities: Assay for amplification and detection of virus Assay for detection of an immune response against the virus Development of vaccination against the virus Development of iRNA based therapeutic agent for reducing the vira titer

Technology Application

Differential diagnosis of respiratory tract infection and detection of the virus Vaccines to prevent infection and disease due to the virus Therapeutic agents to prevent or ameliorate disease due to the virus

Detailed Technology Description

This technology is directed to address a group of picornaviruses (rhinovirus C) associated with respiratory infection. This invention encompasses: Isolated nucleic acid sequences Peptides associated with isolated nucleic acid sequences

Country/Region

USA

For more information, please click Here